Clinical Trial Update: Safety and Efficacy of Oral TXA in Reducing Blood Loss and Transfusion in Hip Fractures [Phase 4]

View source ↗

Summary

Phase 4 trial update on safety and efficacy of oral tranexamic acid in reducing blood loss and transfusion in hip fracture patients; study terminated with resul…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hip Fracture

Drugs mentioned

• Oral TXA (tranexamic acid)

Snippet

Sponsor: Yale University | Conditions: Hip Fractures, Blood Loss | Phase 4 | Status: TERMINATED | Results posted: 2019-07-29